about
Overview of the biology of type I interferonsConstitutive type I interferon modulates homeostatic balance through tonic signalingFabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoidsPregnancy-induced gene expression changes in vivo among women with rheumatoid arthritis: a pilot study.Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammationSoluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in miceCase treated with triple therapy of lamivudine, interferon-β and prednisolone for acute exacerbation of chronic hepatitis B during pregnancyIndependent and interdependent immunoregulatory effects of IL-27, IFN-β, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis.Interleukin 27: a double-edged sword for offense and defense.Type I interferon in organ-targeted autoimmune and inflammatory diseases.The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases.Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases.The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment.Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy.[Interferon-β1b in multiple sclerosis therapy: more than 20 years clinical experience].Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid are less likely to develop neutralizing antibodies against interferon beta.Activation of Type I Interferon Signal Pathway in Patients with Multiple Sclerosis by the Russian Analog of β-Interferon-1b (transcriptional profiling data)
P2860
Q21195364-AA13BBA0-4CA1-499D-9189-66A21A356C97Q28260631-E60AB111-F486-4CDB-94DE-9CDC57E12BECQ28477392-C9F1345D-FB91-4376-A5CE-F95C404D76D4Q33730831-46645211-3B5D-4825-B1C5-3433A4F6B82EQ34097852-5E938671-A4DF-48F4-BCD9-07FD7677E0EDQ35512654-3B66787F-28B5-4BB9-9361-7510DD61C43CQ36512209-04B16B18-20C9-4466-B887-379C801157D4Q36801132-0B62A413-6206-44C7-83D2-563186803542Q37264717-18BDA644-F6C0-4BDB-B875-3B10233705E5Q37607910-BF9EC89F-DCE4-4A45-8671-D0BBDFBEEB2CQ37838003-9EF07455-C289-4929-A283-715288D7ABDBQ38132555-5F882E3B-5D00-4B28-BB48-0EF9EC76CF3FQ41874184-6E0C9F1D-0D94-4C98-9E60-299EE11C1F03Q41958567-E145BCF6-0206-4F93-8699-1C56972A4F6BQ42326768-6F866174-506C-4A63-B757-02615509AF9EQ44765320-243C9074-8DDF-4BE2-82E0-9BFC61CB1D47Q45155454-E1FBF8F2-3098-4393-952D-00AB398ADCD8Q45761961-7BFE8F72-2F05-4384-BC64-805DF01E34FCQ57417455-4EBAB2D4-C1ED-4936-9C3C-B24A8CB99B18
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Interferon-beta1b in multiple sclerosis.
@en
type
label
Interferon-beta1b in multiple sclerosis.
@en
prefLabel
Interferon-beta1b in multiple sclerosis.
@en
P2860
P356
P1476
Interferon-beta1b in multiple sclerosis.
@en
P2093
Mathias Buttmann
Peter Rieckmann
P2860
P304
P356
10.1586/14737175.7.3.227
P577
2007-03-01T00:00:00Z